RecruitingNCT04675138

Development of a Clinical Decision Support System With Artificial Intelligence for Cancer Care


Sponsor

National University Hospital, Singapore

Enrollment

1,000 participants

Start Date

Aug 20, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

Clinical Decision Support Systems (CDSSs) to augment clinical care and decision making. These are platforms which aim to improve healthcare delivery by enhancing medical decisions with targeted clinical knowledge, patient information, and other health information. In view of the benefit of developing a CDSS, we sought to develop an alternative CDSS for oncologic therapy selection through a partnership with Ping An Technology (Shenzhen, China), beginning with gastric and oesophagal cancer. This would be done in a piecemeal fashion, with the prototype platform utilizing only international guidelines and high-quality published evidence from journals to arrive at case-specific treatment recommendations. This platform would then be evaluated by comparing its recommendations with that from the multidisciplinary tumour boards of several tertiary care institutions to determine the concordance rate.


Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This study is developing and testing an AI-powered clinical decision support system to help doctors make better treatment decisions for patients with cancers of the stomach, esophagus, and the area where the two join (the gastroesophageal junction). Researchers are using patient data from past cases to train and validate the AI model. **You may be eligible if you:** - Have been diagnosed with primary gastric (stomach) adenocarcinoma, including early-stage forms, OR - Have esophageal cancer (including adenocarcinoma, squamous cell carcinoma, or early-stage forms), OR - Have cancer at the junction of the esophagus and stomach - Are participating in the prospective (future) part of the study **You may NOT be eligible if you:** - Have a different type of primary cancer involving the stomach or esophagus (not the types specified) - Have been diagnosed with another cancer previously (in certain categories) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo intervention will be provided to the subject

No intervention will be provided to the subject


Locations(9)

University Hospital Leipzig

Leipzig, Germany

National Cancer Centre Hospital East

Kashiwa, Japan

National University Hospital

Singapore, Singapore

National Cancer Centre Singapore

Singapore, Singapore

Ng Teng Feng General Hospital

Singapore, Singapore

Tan Tock Seng Hospital

Singapore, Singapore

Seoul National University Hospital

Seoul, South Korea

Karolinska Institute Hospital

Stockholm, Sweden

The University of Edinburgh

Edinburgh, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04675138


Related Trials